Cell-cell Adhesion Mediated by CD8 and MHC Class I Molecules
Affiliations
CD4 and CD8 are cell-surface glycoproteins expressed on mutually exclusive subsets of peripheral T cells. T cells that express CD4 have T-cell antigen receptors that are specific for antigens presented by major histocompatibility complex class II molecules, whereas T cells that express CD8 have receptors specific for antigens presented by MHC class I molecules (reviewed in ref. 1). Based on this correlation and on the observation that anti-CD4 and anti-CD8 antibodies inhibit T-cell function, it has been suggested that CD4 and CD8 increase the avidity of T cells for their targets by binding to MHC class II or MHC class I molecules respectively. Also, CD4 and CD8 may become physically associated with the T-cell antigen receptor, forming a higher-affinity complex for antigen and MHC molecules, and could be involved in signal transduction. Cell-cell adhesion dependent CD4 and MHC II molecules has recently been demonstrated. To determine whether CD8 can interact with MHC class I molecules in the absence of the T-cell antigen receptor, we have developed a cell-cell binding assay that measures adhesion of human B-cell lines expressing MHC class I molecules to transfected cells expressing high levels of human CD8. In this system, CD8 and class I molecules mediate cell-cell adhesion, showing that CD8 directly binds to MHC class I molecules.
CD8α and CD70 mark human natural killer cell populations which differ in cytotoxicity.
Rey C, Jones K, Stacey K, Evans A, Worboys J, Howell G Front Immunol. 2025; 16:1526379.
PMID: 40046047 PMC: 11880019. DOI: 10.3389/fimmu.2025.1526379.
Structure, function, and immunomodulation of the CD8 co-receptor.
Srinivasan S, Zhu C, McShan A Front Immunol. 2024; 15:1412513.
PMID: 39253084 PMC: 11381289. DOI: 10.3389/fimmu.2024.1412513.
Evolution of T cells in the cancer-resistant naked mole-rat.
Lin T, Rubinstein N, Fong N, Smith M, Craft W, Martin-McNulty B Nat Commun. 2024; 15(1):3145.
PMID: 38605005 PMC: 11009300. DOI: 10.1038/s41467-024-47264-x.
CD3 downregulation identifies high-avidity human CD8 T cells.
Clutton G, Weideman A, Mischell M, Kallon S, Conrad S, Shaw F Clin Exp Immunol. 2023; 215(3):279-290.
PMID: 37950348 PMC: 10876116. DOI: 10.1093/cei/uxad124.
Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID-19 survivors.
Jia C, Zhou Z, Pan W, Zhang P, Yang M, Zhao M J Med Virol. 2022; 95(1):e28340.
PMID: 36420584 PMC: 10107439. DOI: 10.1002/jmv.28340.